REVIEW ARTICLE
J O U R NA L O F A DVA N C E NA N O B I O T E C H N O L O G Y | ISSN: 2581-3234 | Vol -9 |Issue 1 | Pages 1-4
Niranjan Rout
ABC Foundation, Cuttack, Odisha, India
Email Id : niranjanrout@gmail.com
Abstract :
The COVID-19 pandemic, caused by SARS-CoV-2, has revealed critical gaps in global healthcare systems, particularly in diagnostics and therapeutics. Conventional tools such as RT-PCR and repurposed drugs, though widely used, face limitations including cost, time, and lack of virusspecific efficacy. Nanotechnology has emerged as a transformative platform to overcome these challenges by exploiting the unique properties of nanomaterials for biomedical applications. In diagnostics, gold nanoparticles, graphene-based sensors, and quantum dots have enabled rapid, sensitive, and point-of-care detection of viral markers, while magnetic nanoparticles support improved imaging and wastewater surveillance. In treatment, nanoparticle-based antivirals, nano-enabled drug delivery systems, and lipid nanoparticle-mediated vaccines—including the Pfizer-BioNTech and Moderna mRNA vaccines have demonstrated unprecedented success. Despite challenges in biosafety, scalability, and regulation, nanotechnology offers immense promise for personalized therapies, smart nanosensors, and pandemic preparedness. This review highlights the role of nanotechnology in reshaping COVID-19 management and its potential for future infectious disease control.
Key Words: Nanotechnology, COVID-19, Diagnostics, Nanomedicine, Vaccines
DOI :http://doi.org/:10.28921/Jan.89
Cite : Rout N, (2025) Nanotechnology-Based Strategies for COVID-19 Diagnosis and Treatment. Journal of Advance Nanobiotechnology. 9(1):1-4